A multicenter experience of thrombotic microangiopathies in Turkey: The Turkish Hematology Research and Education Group (ThREG)-TMA01 study
TRANSFUSION AND APHERESIS SCIENCE, vol.57, no.1, pp.27-30, 2018 (SCI-Expanded, Scopus)
- Publication Type: Article / Article
- Volume: 57 Issue: 1
- Publication Date: 2018
- Doi Number: 10.1016/j.transci.2018.02.012
- Journal Name: TRANSFUSION AND APHERESIS SCIENCE
- Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
- Page Numbers: pp.27-30
- Hacettepe University Affiliated: Yes
Abstract
Thrombotic microangiopathies (TMAs) are rare, but life-threatening disorders characterized by microangiopathic hemolytic anemia and thrombocytopenia (MAHAT) associated with multiorgan dysfunction as a result of microvascular thrombosis and tissue ischemia. The differentiation of the etiology is of utmost importance as the pathophysiological basis will dictate the choice of appropriate treatment.